PR Newswire: news distribution, targeting and monitoring
Nov 5 2012

SUNNYVALE, Calif., Nov. 5, 2012 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that Philippe Jacon, currently CEO of the Foundation of Innovative New Diagnostics (FIND), will join Cepheid in January 2013 in the newly created position of Executive Vice President of Emerging Markets. In his new position, Mr. Jacon will be responsible for Cepheid's emerging commercial opportunities in Asia Pacific, India, Eastern Europe, sub-Saharan Africa and Latin America. Additionally, he will be responsible for the High Burden Developing Country (HBDC) program.

"Philippe brings more than two decades of commercial diagnostics and medical experience to the Cepheid team," said John Bishop, Cepheid's Chief Executive Officer. "Combined with his most recent experience in the not-for-profit diagnostics business, Philippe is an excellent addition to lead our Emerging Markets group and I look forward to welcoming him to the team in early January."

Mr. Jacon will be joining Cepheid from FIND where he worked extensively with Cepheid's team on the HBDC program. Previously, he was Director General of the European Diagnostics Manufacturers Association and Worldwide President of Becton Dickinson Diagnostics Systems, where he spent most of his career in a variety of businesses, geographies and executive positions.

"With more than eight hundred systems placed in less than two years, the HBDC program clearly highlights the unique potential of the GeneXpert System to contribute accurate and fast molecular diagnostics in some of the most remote locations in the world," said Philippe Jacon. "If this system can change lives in HBDCs, its potential in more developed, commercial markets is truly significant.  I look forward to driving adoption of the GeneXpert System and the growing menu of Xpert tests in both commercial and HBDC markets."

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.

Forward-Looking Statements

This press release contains forward-looking statements that are not purely historical regarding Cepheid's or its management's intentions, beliefs, expectations and strategies for the future, including those relating to future business expansion and financial results. Because such statements deal with future events, they are subject to various risks and uncertainties, and actual results could differ materially from the Company's current expectations. Factors that could cause actual results to differ materially include risks and uncertainties such as those relating to: the growth of the HBDC program and sales in developing global markets; long sales cycles in such markets; obtaining regulatory clearances to sell our products in various countries; matters relating to personnel; unforeseen supply, development and manufacturing problems; the Company's reliance on distributors in some regions to market, sell and support its products; the Company's ability to manage geographically-dispersed operations; and underlying market conditions worldwide. Readers should also refer to the section entitled "Risk Factors" in Cepheid's Annual Report on Form 10-K, its most recent Quarterly Report on Form 10-Q, and its other reports filed with the Securities and Exchange Commission. All forward-looking statements and reasons why results might differ included in this release are made as of the date of this press release, based on information currently available to Cepheid, and Cepheid assumes no obligation to update any such forward-looking statement or reasons why results might differ.

For Media Inquiries:

For Investor Inquiries:

 

Jared Tipton

Cepheid Corporate Communications

Tel: (408) 400 8377

communications@cepheid.com

 

Jacquie Ross, CFA

Cepheid Investor Relations

Tel: (408) 400 8329

investor.relations@cepheid.com

SOURCE Cepheid



RELATED LINKS
http://www.cepheid.com

Questions?

Can I help you? Drop me a line and let me know. 

Blogger Services

Customized Newsfeeds

Don't let the name PR Newswire for Journalists dissuade you. This is a great service for bloggers. Any content creator -- whether you're a journalist, freelancer or blogger -- can set up a customized profile to receive releases based on preferences. You also have access to hi-res photos, media-only content such as media advisories and embargoed releases, and experts via ProfNet.

ProfNet

Need expert sources? Check out ProfNet, a service that helps journalists, bloggers, authors, and other content creators connect with experts -- at no charge. Sending a query is easy: Just fill out a form detailing the kind of expertise you need, how you want to be contacted, and your deadline. ProfNet will do the rest. You also can sign up for a weekly "tip sheet" of experts and story ideas. Visit ProfNet for more info or go directly to the query form.

ProfNet Connect

ProfNet Connect is a free, interactive online community where PR professionals, experts, and media professionals can network and engage with one another. Via profiles, forums and blogs, subject-matter experts can position themselves as the go-to source for content creators and journalists. In turn, content creators can search the site by keyword to find the experts they need. The site also features enhanced profile capabilities, allowing users to easily add multimedia components -- photos, videos, white papers and more -- to their profiles.

News Widget

Our widget allows you to display PR Newswire content on your site with very little back-end programming required.  You not only get the headline, but also the body of text of the news release, keeping the user on your site at all times.  In order to do so, the difference between our Widget and other widgets is at the end of the sign-up process, you will be provided with two pieces of source code -- one for the page where the Widget itself will be displayed and one for the pages that will display the body of text of each news release.  In addition, the sign-up process allows you to have 100 percent control over every aspect of the Widget's appearance, so that the Widget can blend in fully with the look and feel of your site. Still not convinced? Here's what one blogger had to say about the widget.

Search
  
  1. Home
  2. News Unfiltered
  3. Blog Posts
  4. Blogger Services
  5. Blogger Events
  6. Contact Us